{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:24:31Z","timestamp":1771039471074,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014630","name":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","doi-asserted-by":"publisher","award":["PHRC-IR 2008"],"award-info":[{"award-number":["PHRC-IR 2008"]}],"id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001688-00"],"award-info":[{"award-number":["MOH-001688-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001327-02"],"award-info":[{"award-number":["MOH-001327-02"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021852","name":"Centre Hospitalier Universitaire de Poitiers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021852","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008966","name":"Soci\u00e9t\u00e9 Francophone du Diab\u00e8te","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.diabet.2025.101658","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:54:44Z","timestamp":1745981684000},"page":"101658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1862-4252","authenticated-orcid":false,"given":"Pierre-Jean","family":"Saulnier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Croyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"de Keizer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiexun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huili","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Ragot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Chi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2025.101658_bib0001","unstructured":"Federation ID. IDF Diabetes Atlas 2021, https:\/\/diabetesatlas.org\/atlas\/tenth-edition\/; 2022 [accessed 13\/01\/2025]."},{"issue":"Suppl 1","key":"10.1016\/j.diabet.2025.101658_bib0002","first-page":"S79","article-title":"Nephropathy in diabetes","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101658_bib0003","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc20-1913","article-title":"Worldwide epidemiology of diabetes-related end-stage renal disease, 2000-2015","volume":"44","author":"Cheng","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101658_bib0004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000514550","article-title":"Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy","volume":"52","author":"Thurlow","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.diabet.2025.101658_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-nutr-071816-064732","article-title":"Trimethylamine N-Oxide, the microbiome, and heart and kidney disease","volume":"37","author":"Zeisel","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.diabet.2025.101658_bib0006","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.nut.2017.08.001","article-title":"Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?","volume":"46","author":"Nowinski","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.diabet.2025.101658_bib0007","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/jcm6090086","article-title":"Gut microbiota-dependent trimethylamine-n-oxide and serum biomarkers in patients with T2DM and advanced CKD","volume":"6","author":"Al-Obaide","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabet.2025.101658_bib0008","doi-asserted-by":"crossref","first-page":"dgaa188","DOI":"10.1210\/clinem\/dgaa188","article-title":"Plasma trimethylamine N-Oxide and risk of cardiovascular events in patients with type 2 diabetes","volume":"105","author":"Croyal","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2025.101658_bib0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41581-022-00647-z","article-title":"Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential","volume":"19","author":"Krukowski","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diabet.2025.101658_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MOL.0000000000000036","article-title":"Metaorganismal nutrient metabolism as a basis of cardiovascular disease","volume":"25","author":"Brown","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.diabet.2025.101658_bib0011","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/dc13-2580","article-title":"Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort","volume":"37","author":"Saulnier","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101658_bib0012","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/dc19-1295","article-title":"association of urine haptoglobin with risk of all-cause and cause-specific mortality in individuals with type 2 diabetes: a transethnic collaborative work","volume":"43","author":"Liu","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101658_bib0013","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2025.101658_bib0014","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in albuminuria and gfr as end points for clinical trials in early stages of ckd: a scientific workshop sponsored by the national kidney foundation in collaboration with the US food and drug administration and European medicines agency","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabet.2025.101658_bib0015","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2025.101658_bib0016","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.kint.2020.07.013","article-title":"International consensus definitions of clinical trial outcomes for kidney failure: 2020","volume":"98","author":"Levin","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabet.2025.101658_bib0017","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1681\/ASN.2016030248","article-title":"Red meat intake and risk of ESRD","volume":"28","author":"Lew","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabet.2025.101658_bib0018","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1038\/s41467-023-39824-4","article-title":"Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide","volume":"14","author":"Andrikopoulos","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.diabet.2025.101658_bib0019","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/ajcn\/nqab152","article-title":"Associations of circulating choline and its related metabolites with cardiometabolic biomarkers: an international pooled analysis","volume":"114","author":"Pan","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabet.2025.101658_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11306-020-01762-3","article-title":"Plasma metabolites associated with chronic kidney disease and renal function in adults from the Baltimore Longitudinal Study of Aging","volume":"17","author":"Yamaguchi","year":"2021","journal-title":"Metabolomics"},{"key":"10.1016\/j.diabet.2025.101658_bib0021","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1681\/ASN.2012101006","article-title":"A combined epidemiologic and metabolomic approach improves CKD prediction","volume":"24","author":"Rhee","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabet.2025.101658_bib0022","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1681\/ASN.0000000000000344","article-title":"The gut microbial metabolite trimethylamine n -oxide, incident ckd, and kidney function decline","volume":"35","author":"Wang","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabet.2025.101658_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244402","article-title":"Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria","volume":"16","author":"Winther","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2025.101658_bib0024","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2022.02.016","article-title":"Association of uremic solutes with cardiovascular death in diabetic kidney disease","volume":"80","author":"Sapa","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabet.2025.101658_bib0025","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1210\/clinem\/dgae009","article-title":"Association between trimethylamine N-Oxide and adverse kidney outcomes and overall mortality in type 2 diabetes mellitus","volume":"109","author":"Yu","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2025.101658_bib0026","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/dc19-0048","article-title":"Utility of plasma concentration of trimethylamine n-oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes","volume":"42","author":"Winther","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101658_bib0027","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/ATVBAHA.120.314139","article-title":"Targeted inhibition of gut microbial trimethylamine N-Oxide production reduces renal tubulointerstitial fibrosis and functional impairment in a murine model of chronic kidney disease","volume":"40","author":"Gupta","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2025.101658_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.780924","article-title":"Rhubarb enema decreases circulating trimethylamine N-Oxide level and improves renal fibrosis accompanied with gut microbiota change in chronic kidney disease rats","volume":"12","author":"Ji","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.diabet.2025.101658_bib0029","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.3390\/nu15173687","article-title":"Changes in choline metabolites and ceramides in response to a DASH-Style diet in older adults","volume":"15","author":"Tate","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.diabet.2025.101658_bib0030","unstructured":"Supplements NIoHOoD. Choline: fact sheet for health professionals, https:\/\/ods.od.nih.gov\/api\/?resourcename=Choline&readinglevel=Health%20Professional&outputformat=HTML; [accessed Feb. 24, 2025]."},{"key":"10.1016\/j.diabet.2025.101658_bib0031","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12882-018-1145-5","article-title":"Asian Americans & chronic kidney disease in a nationally representative cohort","volume":"20","author":"Kataoka-Yahiro","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.diabet.2025.101658_bib0032","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2337\/dc06-0003","article-title":"South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients","volume":"29","author":"Chandie Shaw","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101658_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020145","article-title":"Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study","volume":"8","author":"Mathur","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.diabet.2025.101658_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.07.021","article-title":"Metabolic, epigenetic, and transgenerational effects of gut bacterial choline consumption","volume":"22","author":"Romano","year":"2017","journal-title":"Cell Host Microbe"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625000539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625000539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:33:51Z","timestamp":1762367631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363625000539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1262363625000539"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101658","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101658"}}